Before I underwent surgery to remove tumors on several organs, I was told it was the only way to determine what cancer I had.

The phase 1/2 study will assess next-generation immunotherapy alone and in combination with an immune checkpoint inhibitor in ...

This year for Thankgiving, I reflected on how my life has been as a breast cancer veteran and how grateful I am for the ...

Researchers have found an increased frequency of severe maternal morbidity and obstetric complications among women who ...

A phase 2 study for patients with HR-positive, HER2-negative metastatic breast cancer will be evaluating alisertib plus ...

In the cancer world — or anywhere — the ability to give thanks in the midst of trials is an acquired skill. It must be ...

With stage 4 colon cancer, I think still think about death, but I’ve learned how to live in the present to enjoy each day I ...

Truqap combination showed a statistically and clinically meaningful improvement in radiographic progression-free survival for ...

For patients with relapsed or refractory CLL, an expert explained that it’s important to understand the order of how ...

Celebrating Thanksgivings after cancer has made me appreciate all aspects of life even more and to truly cherish times of ...

An expert discusses the next steps for patients with metastatic breast cancer after their disease no longer responds to ...

The FDA will review an application to consider potential approval of Nubeqa plus androgen deprivation therapy for metastatic ...